Zentalis Pharmaceuticals announced interim overall survival data from its DENALI Part 1b study showing a median survival of 15.8 months in Cyclin E1-positive platinum-resistant ovarian cancer patients treated with azenosertib monotherapy. This compares favorably to 7.5 months in Cyclin E1-negative patients and supports further development of azenosertib in this biomarker-selected group. The data will be presented at the ESMO Congress 2026, with ongoing Phase 2 and Phase 3 trials aiming for regulatory approval. No new safety concerns were reported, highlighting azenosertib's potential as a targeted oral treatment option for this hard-to-treat cancer subset.
Zentalis Pharmaceuticals' interim overall survival data for azenosertib in ovarian cancer highlights a median survival of 15.8 months in Cyclin E1-positive patients. For readers following the health sector, here is Pluang's market snapshot as of Oct 19, 2026 05:21 WIB: out of 150 priced US health stocks, 29 rose and 118 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 10.27 with a -12.67% change and a typical hold time of 8 days, NVAX (Novavax Inc) at USD 11.26 with a -12.17% change and a 59-day hold time, and SLS (SELLAS Life Sciences Group Inc.) at USD 9.98 with a -11.99% change and a 4-day hold time.
Hayati®, a UK-based technology and vaping brand, partnered with elrow at the Edinburgh Festival to launch the "TURN UP WITH HAYATI®" activation. This collaboration featured a dedicated space with interactive activities, special festival edition produ...
FREELANDER participated in the 2026 Chery International User Summit in Wuhu, China, showcasing the international variant of its FREELANDER 8 model through a day-and-night program on October 19. The day featured the first international test drive on c...
Bitcoin (BTC) climbed 0.89% to surpass $82,000, with Ether (ETH) also gaining 0.45% near $2,400. The crypto market showed mixed performance: Monero (XMR) and Zcash (ZEC) rose over 2%, while sectors like Layer 1 and CeFi advanced modestly. However, so...
The Bitwise NEAR ETF (NRR) held 16.5 million NEAR tokens valued at over $82 million as of mid-October, with all assets staked to earn rewards. The fund reported a 3.31% net staking reward rate on Oct. 16, lower than the 4.94% gross rate, due to fees ...
South32 Ltd began fiscal year 2027 with an 11% rise in copper production at its Sierra Gorda mine, driven by higher ore grades and ongoing expansion efforts including a new grinding line to increase capacity by 25%. The company also saw a 14% increas...
